The role of the dopamine- and cyclic AMP-regulated phosphoprotein of M-r 32
,000 (DARPP-32) in dopaminergic regulation of gene transcription in striatu
m and globus pallidus was examined. Mice with targeted disruption of the ge
ne encoding DARPP-32, its homologue, inhibitor-1, or both, were used. Pharm
acological characterization showed that mutant mice had normal basal levels
of dopamine D-1 and D-2 receptors and adenosine A(2A) receptors. Basal exp
ression levels of the striatonigral-specific neuropeptides substance P and
prodynorphin and the immediate early genes c-fos and NGFI-A were also unalt
ered in mutant mice. A full D-1 receptor agonist, SKF 82958, up-regulated t
he expression of these neuropeptides and immediate early genes significantl
y more in wild-type mice than in mice lacking DARPP-32. Moreover, the addit
ive stimulation of SKF 82958 and quinelorane, a D-2 receptor agonist, on c-
fos mRNA in globus pallidus was significantly decreased in DARPP-32 and DAR
PP-32/I-1 knockout mice. No changes in dopamine receptor-induced gene expre
ssion were found in I-1 knockout mice. These results demonstrate an importa
nt involvement of DARPP-32 in dopamine receptor-mediated regulation of gene
expression both in striatal neurons, which are enriched in DARPP-32, and i
n pallidal neurons, which do not contain DARPP-32.